APA (7th ed.) Citation

Honma, K., Nakayama, Y., Tamaki, A., Uehara, M., Teruya, T., Yabiku, T., . . . Masuzaki, H. Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan. The Japan Endocrine Society.

Chicago Style (17th ed.) Citation

Honma, Ken-ichiro, et al. Impact of the Transition from Radioimmunoassay (RIA) to Chemiluminescent Enzyme Immunoassay (CLEIA) for the Measurement of Plasma Aldosterone Concentration (PAC) on the Diagnosis of Primary Aldosteronism (PA) via Retrospective Analyses in Okinawa, Japan. The Japan Endocrine Society.

MLA (9th ed.) Citation

Honma, Ken-ichiro, et al. Impact of the Transition from Radioimmunoassay (RIA) to Chemiluminescent Enzyme Immunoassay (CLEIA) for the Measurement of Plasma Aldosterone Concentration (PAC) on the Diagnosis of Primary Aldosteronism (PA) via Retrospective Analyses in Okinawa, Japan. The Japan Endocrine Society.